Efficacy of Aspirin and L-arginine in High Risk Preeclamptic
Efficacy of the Combination of Acetylsalicylic Acid and L-arginine to Prevent Preeclampsia in Pregnant High Risk
Sponsor: MD Diego Hernández Molina
Suspended
COVID-19 pandemic
This PHASE2 trial investigates High Risk Pregnancy and is currently suspended. MD Diego Hernández Molina leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Suspended PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Suspended PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Suspended PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Suspended PHASE2
Status: Unknown Status → Suspended
-
Nov 2020 — Dec 2020 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Nov 2018 — Nov 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- MD Diego Hernández Molina
- PhD Ernesto Javier Ramírez Lizardo
- PhD Fernando Grover Páez
- PhD Sylvia Elena Totsuka Sutto
- University of Guadalajara
For direct contact, visit the study record on ClinicalTrials.gov .